Amazing Research Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 09-07-2024
- Paid Up Capital ₹ 0.50 M
as on 09-07-2024
- Company Age 26 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 13.00 Cr
as on 09-07-2024
- Revenue 29.66%
(FY 2022)
- Profit -1.40%
(FY 2022)
- Ebitda 213.17%
(FY 2022)
- Net Worth 648.55%
(FY 2022)
- Total Assets 21.93%
(FY 2022)
About Amazing Research Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹13.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rashmi Gupta, Rama Shanker, and Rajesh Verma serve as directors at the Company.
- CIN/LLPIN
U99999DL1998PLC095297
- Company No.
095297
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
31 Jul 1998
- Date of AGM
26 May 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Amazing Research Laboratories Limited offer?
Amazing Research Laboratories Limited offers a wide range of products and services, including Antipyretic Medication, Paracetamol Tablets, Arthritic Drugs, Dexamethasone Injection, Amoxicillin drugs, Amoxicillin Potassium Clavulanate Tablet, Pain Relief Drugs & Pharmaceuticals.
Who are the key members and board of directors at Amazing Research Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rashmi Gupta  | Director | 27-Mar-2023 | Current |
| Rama Shanker | Director | 20-May-2017 | Current |
| Rajesh Verma | Director | 18-Feb-2007 | Current |
Financial Performance and Corporate Structure Insights of Amazing Research Laboratories.
Amazing Research Laboratories Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.66% increase. The company also saw a slight decrease in profitability, with a 1.4% decrease in profit. The company's net worth Soared by an impressive increase of 648.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amazing Research Laboratories?
In 2020, Amazing Research Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 02 Jun 2021 | ₹6.00 Cr | Satisfied |
Yes Bank Limited Creation Date: 29 Jan 2020 | ₹5.00 Cr | Satisfied |
Icici Bank Limited Creation Date: 03 Mar 2011 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Amazing Research Laboratories?
Unlock and access historical data on people associated with Amazing Research Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amazing Research Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amazing Research Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
